Business · 26/12/2023Updated: 10/17/2026 · 1 min read
FDA Releases Final Guidance for Rare Diseases Drug Development
The FDA has released a final guidance to help pharmaceutical companies develop effective treatments for rare diseases, building on a previous draft guidance issued in 2019.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →